(MedPage Today) — CHICAGO — Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in the near future, with results after 1 year reported here from one of its key phase III trials.
Further…
Genetic study identifies earliest-known dog, dating to 15,800 years ago
Genetic study identifies earliest-known dog, dating to 15,800 years ago Source: www.channelnewsasia.com






